Discontinuation report ACCOLATE TAB 20 MG
| Report ID | 257942 |
| Drug Identification Number | 02236606 |
| Brand name | ACCOLATE TAB 20 MG |
| Common or Proper name | test |
| Company Name | ASTRAZENECA CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ZAFIRLUKAST |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 1x10ml |
| ATC code | R03DC |
| ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| Reason for discontinuation | Manufacturing issues |
| Anticipated discontinuation date | 2026-03-03 |
| Actual discontinuation date | 2026-05-10 |
| Remaining supply date | |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | test |
| Company comments | test |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: [email protected]. Veuillez contacter le Service d'information médicale d'AstraZeneca Canada pour toute question spécifique au 1-800-668-6000 (EN) ou au 1-800-461-3787 (FR) ou par courriel : [email protected]. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-02-12 | French | Compare |
| v1 | 2026-02-12 | English | Compare |
Showing 1 to 2 of 2